Canada markets open in 3 hours 46 minutes

NeuBase Therapeutics Inc (O7P.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
0.3508-0.0044 (-1.24%)
As of 10:50AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-09-30
2021-09-30
2020-09-30
Total Revenue
0
0
0
0
Operating Expenses
Research Development
18,431
21,449
14,363
6,946
Selling General and Administrative
11,530
11,870
12,202
10,123
Total Operating Expenses
29,961
33,318
26,565
17,069
Operating Income or Loss
-29,961
-33,318
-26,565
-17,069
Interest Expense
10.696
24.047
32.33
7.686
Total Other Income/Expenses Net
-739.692
-582.62
1,176
-307.528
Income Before Tax
-30,417
-33,776
-25,409
-17,385
Income from Continuing Operations
-30,417
-33,776
-25,409
-17,385
Net Income
-30,417
-33,776
-25,409
-17,385
Net Income available to common shareholders
-30,417
-33,776
-25,409
-17,385
Basic EPS
-3.44
-20.80
-18.60
-17.80
Diluted EPS
-3.44
-20.80
-18.60
-17.80
Basic Average Shares
2,825
1,624
1,365
981.014
Diluted Average Shares
2,825
1,624
1,365
981.014